Nomenclature of Ugi peptoids and peptide-Ugi peptoid hybrids
The nomenclature of Ugi units is less trivial than the one for conventional peptides ( Figure S1 , a) or polyglycinic peptoids ( Figure S1 , b) or respective hybrid structures ( Figure S1 , c). This is because any possible amino acid may be employed in the reaction -not only glycine and its derivatives. Furthermore, the Ugi-MCR provides two additional R-groups based on the aldehyde and isonitrile. In an Ugi peptoid unit the employed amino acid ( Figure S1 , c, blue) builds the peptoid backbone. The pendant group at the amide nitrogen is composed of the main part of the actual Ugi scaffold (red), which still carries the R-groups of the aldehyde (light blue) and isocyanide (marine blue). As the orange scaffold is repetitive throughout every Ugi sequence, it does not occur separately in the nomenclature of Ugi peptoid units.
However, the structure of the aldehyde and isocyanide are reported in the nomenclature of those structures. A representative example is discussed ( Figure   S1 , e). Conventional peptide sequences (green) maintain their single letter code without any change. When an Ugi peptoid sequence is described, amino acids (blue) keeps their letter code (in comparison to the nomenclature of polyglycines), as all available amino acids can be incorporated and not only glycines. Then, in brackets the R-group of the aldehyde (light blue) is reported first (caution: when e.g.
butyraldehyde H 3 C-(CH 2 ) 2 -CHO is employed, it loses the aldehyde carbon in the nomenclature and is reported as nPr consequently). Second, the R-group of the isocyanide is reported in the bracket. Thereby, the R-group is described as attached to the isocyanide.
Example:
Starting compound PG-Lys-OH Undecanal Structure of a conventional peptoid (polyglycine) and its nomenclature as letter code. c. Structure of a peptide-peptoid (polyglycine) hybrid and its nomenclature as letter code. d. Structure of an Ugi unit along a peptoid backbone and its pendant Rgroups, as well as their origin from amino acid (R AA , blue), aldehyde (R A , light blue) and isocyanate (R IC , marine blue). The Ugi-scaffold (wine red) does not occur in the nomenclature for Ugi peptoid sequences. e. Structure of a peptide-Ugi peptoid hybrid and its nomenclature in letter code.
Experimental Section

Materials, General Methods and Instrumentation
All reagents, chemicals and solvents were purchased from commercial suppliers and used without further purification unless stated otherwise.
Nuclear Magnetic Resonance (NMR) spectra were recorded on a Bruker AV-III trifluoroacetate (AgTFA) as cationization agent (10 mg·mL −1 ) and sample (10 mg·mL −1 ) were mixed together in a 9:1:1 volume ratio for a total volume of 75 μL.
2 μL of the mixture was applied to the target plate. Spectra were recorded in reflectron mode and the mass spectrometer was calibrated with a peptide mixture up to 6000 Da.
Reversed Phase High Performance Liquid Chromatography (RP-HPLC) on a
analytical HPLC (Alliance HPLC System, Waters, UK) using a X-bridge column (C18, 3.5 μm, 4.6 × 150 mm) with a gradient of water/acetonitrile was conducted for the analysis of the oligomers.
Peptide synthesiser: The peptides were synthesized on an automated peptide synthesiser (Liberty Blue, CEN, UK) using standard 9-fluorenylmethoxycarbonyl (Fmoc) based solid phase chemistry on a 4-methylbenzhydrylamine (MBHA) Rink amide resin (Novabiochem, . Amino acid couplings were performed using 4 equivalents of Fmoc protected amino acids (Novabiochem), 4 eq. MEOH, 80% H2O and 1 wt% Hybrid 8 in 10% THF and 90% H2O, were pipetted into a 0.2 mm path length, with absorbance less than 2 at any point being reported.
HR-ESI MS and
Measurements were recorded with a 0.5 nm bandwidth, 1 mm step and 1 second collection time per point The CD signal for the background was subtracted from the CD signal of the sample, and molar ellipticity was calculated.
Cryogenic Transmission Electronic Microscopy (Cryo-TEM). Vitrified specimens were prepared using an automated FEI Vitrobot device using Quantifoil 3.5/1 holey carbon copper grids with a hole size of 3.5 μm. Before use, the grids were plasma cleaned using a Gatan Solarus 9500 plasma cleaner and then transferred into an environmental chamber of a FEI Vitrobot at room temperature and 100% humidity.
Following this, the sample solution was applied onto the grid, and it was blotted twice for 5 s and then vitrified in a 1/1 mixture of liquid ethane and propane at a temperature of −180 °C. The grids with vitrified sample solution were maintained at liquid nitrogen temperature. After this, they were cryotransferred to the microscope.
Imaging was carried out using a field emission cryo-electron microscope (JEOL JEM-3200FSC) operating at 200 kV. Images were taken in bright field mode and using zero loss energy filtering (Ω type) with a slit width of 20 eV. Micrographs were recorded using a Gatan Ultrascan 4000 CCD camera. Specimen temperature was maintained at −187 °C during the imaging.
Small-angle X-ray scattering. Collection of small-angle X-ray scattering (SAXS) data was performed on the bioSAXS beamline B21, at Diamond Light Source, United
Kingdom. Solutions containing 1% hybrid 5 (H2O), 1% Hybrid 3 dissolved in 20%
MEOH, 80% H2O and 1% Hybrid 8 in 10% THF and 90% H2O were loaded in PCR tubes in an automated sample changer. Samples (30µl) were loaded into a temperature controlled quartz cell capillary and exposed for 10 seconds, 18 frames at 15oC. Data was collected using a dectris pilatus 2m detector. Background was manually subtracted using SCATTER . Form factor modelling was done using SASFIT.
Synthesis of Monomers
Synthesis of Polystyrene Butyl Amine Resin
DMF, reflux, 18 h quant.
Cl NHnBu nBuNH 2
To a suspension of crosslinked (chloromethyl)polystyrene (5.5 mmol/g Cl loading, 10.0 g, 55.0 mmol) and DMF (40 mL) nbutylamine (20.1 g, 275 mmol) was added and the mixture was stirred under reflux over night. The polystyrene butyl amine resin was filtered off and washed with DCM (250 mL), dried under vacuum and used as obtained. Oxalylchloride (1.00 g, 7.88 mmol) and dry DCM (30 mL) were cooled to -78 o C.
Synthesis of (2R,4S,5R)-2-(acetoxymethyl)-6-((3-oxopropyl)thio)tetrahydro-2H-pyran-3,4,5-triyl triacetate
Synthesis of MeO-PEG 550 -CHO
DMSO (3 mL) was added and the reaction mixture was stirred at -78 o C for 30 min. PEG methyl ether (M n = 500 g/mol, 2.63 g, 5.25 mmol) was added and the reaction mixture was stirred at -78 o C for 30 min. The mixture was warmed slowly until the PEG methyl ether was dissolved and it was cooled again to -78 o C. Triethylamine (7 mL) was added dropwise and it was stirred at constant temperature for 1 h. After warming to room temperature, the solvent was removed under reduced pressure. Chloroform (20 mL) and water (20 mL) and the phases were separated. The combined organic layers were dried over MgSO 4 and the solvent was evaporated. A yellow oil was obtained (1.98 g, 75%). (4.00 eq), the coupling reagent (4.00 eq) and DIC (4.00 eq) were added to the vessel containing the deprotected resin and the mixture was stirred using nitrogen flux under microwave irradiation (45 W) at 75 °C for 600 sec. After each coupling reaction, the resin was submitted to two deprotection cycles as reported in (1).
H NMR (CDCl
(3) Manual Fmoc-Solid Phase Peptide Synthesis (Fmoc-SPPS).
Peptide units were synthesised on resin following the conventional Fmoc strategy of solid phase peptide synthesis. The Fmoc protected amino acids (4.00 eq), HOBt (4.00 eq) and DIC (4.00 eq) were added to the vessel containing the deprotected resin and the mixture was stirred in DMF at 40 °C for 2 h. The resin was washed with 2 x DCM (10 mL) and 2 x DMF (10 mL). After each coupling reaction, two deprotection cycles using DMF/piperidine 3/1 v/v (12 mL) were conducted and the resin was washed with 3 x MeOH/CHCl 3 1/3 v/v (10 mL). Kaiser test was conducted to determine the success of the reaction.
(4) Manual Ugi-Fmoc-Solid Phase Peptoid Synthesis (Ugi-Fmoc-SPPS).
Peptoid units were synthesised on resin following Ugi-Fmoc strategy of solid phase peptoid synthesis. The deprotected resin and aldehyde (4.00 eq) were stirred in the minimal amount of MeOH/CHCl 3 3/1 v/v (10 mL) at 60 °C for 30-60 min in order to ensure the imine formation. Fmoc protected amino acids (5.00 eq) and isocyanide (6.00 eq) were added and the reaction was stirred at 60 °C for 2-6 h. The resin was washed with 2 x DCM (10 mL) and 2 x DMF (10 mL). After each Ugi reaction, two deprotection cycles using DMF/piperidine 3/1 v/v (12 mL) were conducted and the resin was washed with with 3 x DCM (10 mL), when peptide coupling was following, or 3 x MeOH/CHCl 3 3/1 v/v (10 mL), when Ugi reaction was following. Positive ESI-MS analysis of crude 5 after cleavage. c. RP-HPLC traces recorded for oligomer 5 after cleavage (99% purity). The analysis was performed with a linear gradient of 98 to 2% water in 20 min using water/MeCN as mobile phase with 0.1% TFA. Figure S18 | HR-ESI MS of 7. top. Experimental spectra of 7. top. Theoretical spectra of 7. bottom. Figure S28 | Schematic presentation of oligomer 8 and its assignment into different fragmentation patterns. a Fitted to monodisperse fractal form factor and a Gaussian generalised coil using 
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